作者: Alexei S. Karpov , Payman Amiri , Cornelia Bellamacina , Marie-Helene Bellance , Werner Breitenstein
DOI: 10.1021/ACSMEDCHEMLETT.5B00102
关键词:
摘要: The discovery of inhibitors targeting novel allosteric kinase sites is very challenging. Such compounds, however, once identified could offer exquisite levels selectivity across the kinome. Herein we report our structure-based optimization strategy a dibenzodiazepine hit 1, discovered in fragment-based screen, yielding highly potent and selective PAK1 such as 2 3. Compound was cocrystallized with to confirm binding an site reveal key interactions. 3 modulated at cellular level due its enabled valuable research interrogate biological functions kinase.